Seeing Is Believing
Currently out of the existing stock ratings of Bruce Jackson, 141 are a BUY (89.24%), 16 are a HOLD (10.13%), 1 are a SELL (0.63%).
Analyst Bruce Jackson, currently employed at BENCHMARK, carries an average stock price target met ratio of 44.72% that have a potential upside of 37.37% achieved within 186 days.
Bruce Jackson’s has documented 283 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UNCY, Unicycive Therapeutics at 15-Sep-2025.
Analyst best performing recommendations are on GNLX (GENELUX COMMON STOCK).
The best stock recommendation documented was for BFRI (BIOFRONTERA) at 12/16/2021. The price target of $220 was fulfilled within 5 days with a profit of $82 (59.42%) receiving and performance score of 118.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
4 years 2 months 9 days ago
(22-Jul-2021)
1/1 (100%)
$6.31 (110.90%)
484
Buy
$10
$9.54 (2073.91%)
$8
4 years 9 months 28 days ago
(03-Dec-2020)
0/3 (0%)
$4.16 (59.27%)
Buy
5 years 3 months 14 days ago
(17-Jun-2020)
2/2 (100%)
$1.27 (34.05%)
162
Buy
$12
$11.54 (2508.70%)
$9
5 years 5 months 15 days ago
(16-Apr-2020)
4/4 (100%)
$2.83 (60.84%)
188
Which stock is Bruce Jackson is most bullish on?
Which stock is Bruce Jackson is most reserved on?
What Year was the first public recommendation made by Bruce Jackson?